Nuformix now focusing on out-licencing NXP002 & NXP004 (LON:NFX)
28 September 2023
UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare sector, is capturing investor attention with its robust market presence and promising financial outlook. With a..
Oric Pharmaceuticals, Inc. (NASDAQ: ORIC), a clinical-stage biopharmaceutical company specializing in cancer resistance therapies, is emerging as a compelling option for investors seeking exposure to the..
Emergent BioSolutions Inc. (NYSE: EBS), a prominent player in the healthcare sector specializing in drug manufacturing, particularly in specialty and generic drugs, is at an intriguing..
Rapport Therapeutics, Inc. (RAPP), a promising player in the biotechnology sector, is drawing significant attention from investors seeking high-growth opportunities in the healthcare industry. Operating out..
For investors keen on the rapidly evolving healthcare sector, Personalis, Inc. (NASDAQ: PSNL) offers a compelling case, especially given its substantial 30% revenue growth. Specializing in..
Autolus Therapeutics plc (NASDAQ: AUTL), a pioneering player in the biotechnology sector, offers a compelling opportunity for investors eager to tap into the dynamic world of..
Orthofix Medical Inc. (NASDAQ: OFIX), a prominent player in the healthcare sector, specializes in medical devices with a focus on spinal and limb reconstruction technologies. As..
MeiraGTx Holdings plc (NASDAQ: MGTX) is making waves in the biotechnology sector, particularly within the niche of genetic medicines. With a market capitalization of $1.01 billion,..
Theravance Biopharma, Inc. (NASDAQ: TBPH), a key player in the healthcare sector, is carving its niche within the biotechnology industry. With a market capitalization of $884.18..
Verastem, Inc. (NASDAQ: VSTM) has been capturing investor attention with its promising biopharmaceutical innovations and the potential for significant stock appreciation. As a development-stage biotechnology company,..
Fortrea Holdings Inc. (NASDAQ: FTRE) stands as a notable entity within the biotechnology industry, offering a spectrum of development solutions for biopharmaceutical products and medical devices...
Tyra Biosciences, Inc. (NASDAQ: TYRA), a clinical-stage biotechnology firm focused on developing precision medicines targeting fibroblast growth factor receptor (FGFR) biology, presents an intriguing opportunity for..
For investors seeking opportunities in the biotechnology sector, Abivax SA (ABVX) presents a compelling case with its significant upside potential and a unanimous positive outlook from..
Altimmune, Inc. (NASDAQ: ALT), a clinical-stage biopharmaceutical company, is currently making waves in the healthcare sector with its focus on innovative therapies for serious liver diseases...
Investors eyeing opportunities in the healthcare sector may find Organogenesis Holdings Inc. (NASDAQ: ORGO) an intriguing prospect, especially given its potential upside of 56.25% based on..
Treace Medical Concepts, Inc. (NASDAQ: TMCI) is garnering attention within the healthcare sector, specifically in the medical devices industry. With a market capitalization of $252.01 million,..
MBX Biosciences, Inc. (NASDAQ: MBX), a clinical-stage biopharmaceutical company, is capturing investor attention with a promising 77.09% potential upside, according to the latest analyst ratings. This..
Bioventus Inc. (NASDAQ: BVS), a prominent player in the healthcare sector specializing in medical devices, has captured the attention of investors with its potential for substantial..
